Furthermore, it is worth evaluating the efficacy of the targeted NEAT1 inhibition in combination with other therapies (including chemotherapy, targeted therapy, and immunotherapy) for treating ovarian cancer. The gene discussed is NEAT1; the disease is ovarian carcinoma.